| Mar 24, 2014
| 3:00 AM
Earlier this General Assembly session, we joined together to announce a transformational economic development commission, a part of a joint economic development agenda that builds on the strategic investments Gov. Martin O'Malley and the legislature...
| Mar 12, 2014
Re "Prices of new drugs tough to take," March 10
I understand the necessity for drug companies to recoup research and development costs. But in regard to a medication that can cure hepatitis C, a spokesman for the maker of one drug that costs about $1,...
| Jun 19, 2014
| 4:54 PM
Wall Street sharks are not the only ones keeping a close watch on the contentious battle for control of Allergan Inc., the Irvine company that makes Botox. So are thousands of the company's scientists and researchers, many of whose jobs may be at risk....
| Feb 6, 2014
| 3:45 PM
WASHINGTON – The United States could be losing its edge in science and technology as emerging nations rapidly increase their investment in research and development, according to new indicators released Thursday by the National Science Board....
| Jan 27, 2014
| 1:05 PM
WASHINGTON – The interim nuclear deal between Iran and world powers will allow Tehran to continue far more research and development on centrifuges to enrich uranium than has been publicly recognized, according to a veteran Washington nuclear...
| May 27, 2014
| 11:07 AM
A day before would-be buyer Valeant Pharmaceuticals is set to unveil a second, unsolicited takeover bid, its acquisition target, Allergan Inc., sought to discredit the company by filing a presentation with regulators questioning the viability of Valeant's...
| May 27, 2014
| 6:33 PM
The billion-dollar takeover battle targeting Irvine-based Allergan is heading into high gear this week with both sides on the attack.
On Tuesday, Allergan Inc., the maker of Botox, launched a broadside against Canadian rival Valeant Pharmaceutics...
| May 28, 2014
| 5:37 PM
For weeks, Valeant Pharmaceuticals had promised a better offer for Botox maker Allergan, but its renewed cash-and-stock offer fell flat with investors and analysts.
After Irvine-based Allergan Inc. rejected a $46-billion offer earlier this month, the...
| May 30, 2014
When she unveils her project later this summer at the NSU Museum of Art Fort Lauderdale, Antonia Wright will have given voices to the homeless. She means that literally: Over the next two months, the Miami performance artist will have visited Broward...
| May 16, 2014
| 8:05 AM
Gov. Martin O'Malley signed a bill Thursday creating a regional 3D printing and additive manufacturing authority in collaboration with the Edgewood Chemical Biological Center at Aberdeen Proving Ground.
The bill, creating the Northeast Maryland Additive...
| May 18, 2014
Research labs closed by pharmaceutical giant Pfizer dot the country: Illinois. Michigan. New Jersey. New York. North Carolina.
Maryland officials don't want this state to join that list.
After Pfizer declared its desire to buy AstraZeneca — which...